Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Hyperlipidemia”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Large-scale testing (Phase 3)Study completedNCT00093899
What this trial is testing

Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Who this might be right for
HyperlipidemiaHypercholesterolemiaHypertriglyceridemia
Organon and Co 611
Large-scale testing (Phase 3)WithdrawnNCT02947334
What this trial is testing

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

Who this might be right for
Primary Hyperlipidemia or Mixed Dyslipidemia
Pfizer
Not applicableLooking for participantsNCT06752772
What this trial is testing

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

Who this might be right for
Elevated Blood PressureHypertensionOverweight/Obesity+3 more
Alexandra Hospital 1,700
Not applicableStudy completedNCT07409636
What this trial is testing

Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 11,991
Large-scale testing (Phase 3)Study completedNCT07295418
What this trial is testing

SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemias
Shenzhen Salubris Pharmaceuticals Co., Ltd. 618
Testing effectiveness (Phase 2)Looking for participantsNCT07223658
What this trial is testing

Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

Who this might be right for
Hyperlipidemia; Mixed
Arrowhead Pharmaceuticals 78
Early research (Phase 1)Study completedNCT06923956
What this trial is testing

Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

Who this might be right for
HypercholesterolaemiaMixed DyslipidaemiaCardiovascular Diseases
Humanis Saglık Anonim Sirketi 14
Not applicableStudy completedNCT04063137
What this trial is testing

Black Rice Anthocyanin in Mixed Meals: Influence on Postprandial Glycaemic and Lipid Responses Among Healthy Individuals

Who this might be right for
Postprandial HyperglycemiaLipidemia
National University of Singapore 24
Large-scale testing (Phase 3)Study completedNCT00139061
What this trial is testing

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

Who this might be right for
Hyperlipidemia
Pfizer 128
Large-scale testing (Phase 3)Study completedNCT00092560
What this trial is testing

Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

Who this might be right for
HypercholesterolemiaHypertriglyceridemia
Organon and Co 587
Not applicableStudy completedNCT01476436
What this trial is testing

Low Carbohydrate Diet - Effect on Plasma Lipids and Metabolic Markers

Who this might be right for
Overweight and ObesityType IIb HyperlipidaemiaHypercholesterolemia Aggravated
Oslo University Hospital 30
Not applicableStudy completedNCT03110432
What this trial is testing

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry

Who this might be right for
DyslipoproteinemiasHypercholesterolemia, FamilialFamilial Hypercholesterolemia - Homozygous+1 more
GWT-TUD GmbH 1,695
Testing effectiveness (Phase 2)Study completedNCT07421232
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 156
Testing effectiveness (Phase 2)Study completedNCT00941603
What this trial is testing

Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 619
Large-scale testing (Phase 3)Study completedNCT01849497
What this trial is testing

Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 149
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Not applicableUnknownNCT03274089
What this trial is testing

Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk

Who this might be right for
HypertensionHyperlipidemia; MixedDiabetes Mellitus
SingHealth Polyclinics 120
Large-scale testing (Phase 3)Study completedNCT02662569
What this trial is testing

Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia

Who this might be right for
Diabetes, Hyperlipidemia, Mixed Dyslipidemia
Amgen 986
Large-scale testing (Phase 3)Study completedNCT05255094
What this trial is testing

Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 464
Not applicableEnded earlyNCT01228019
What this trial is testing

Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,166
Load More Results